{
	"info": {
		"_postman_id": "e9dff46b-c1f3-48aa-81de-5e5deee77017",
		"name": "Clinvar-Submitter Production",
		"schema": "https://schema.getpostman.com/json/collection/v2.1.0/collection.json"
	},
	"item": [
		{
			"name": "submission 2 Records w Errors",
			"request": {
				"method": "POST",
				"header": [
					{
						"key": "Content-Type",
						"name": "Content-Type",
						"type": "text",
						"value": "application/json"
					}
				],
				"body": {
					"mode": "raw",
					"raw": "[{\n    \"@context\": \"http://dataexchange.clinicalgenome.org/interpretation/json/context\",\n    \"assertionMethod\": {\n        \"id\": \"_:b0\",\n        \"label\": \"Hearing Loss ACMG Specifications v1 2018\",\n        \"type\": \"VariantPathogenicityInterpretationGuideline\",\n        \"url\": \"https://submit.ncbi.nlm.nih.gov/ft/byid/vroiax8b/hearing_loss_acmg_specifications_v1_2018.pdf\"\n    },\n    \"condition\": [\n        {\n            \"phenotype\": [\n                {\n                    \"id\": \"HP:0000001\"\n                },\n                {\n                    \"id\": \"HP:0000002\"\n                }\n            ],\n            \"id\": \"_:b4\",\n            \"inheritancePattern\": {\n                \"id\": \"HP:0000007\",\n                \"label\": \"Autosomal recessive inheritance\"\n            },\n            \"type\": \"GeneticCondition\"\n        }\n    ],\n    \"contribution\": [\n        {\n            \"agent\": {\n                \"id\": \"http://curation.clinicalgenome.org/affiliation/10007\",\n                \"label\": \"ClinGen Hearing Loss Expert Panel\",\n                \"type\": \"Agent\"\n            },\n            \"contributionRole\": {\n                \"id\": \"SEPIO:0000155\",\n                \"label\": \"approver\"\n            },\n            \"id\": \"_:b1\",\n            \"type\": \"Contribution\"\n        },\n        {\n            \"agent\": \"http://curation.clinicalgenome.org/affiliation/10007\",\n            \"contributionDate\": \"2018-10-02T00:00:00\",\n            \"contributionRole\": {\n                \"id\": \"SEPIO-CG:97010\",\n                \"label\": \"publisher\"\n            },\n            \"id\": \"_:b2\",\n            \"type\": \"Contribution\"\n        }\n    ],\n    \"description\": \"The allele frequency of the p.Asn346His variant in the USH2A gene is 0.016% (20/126318) of European (Non-Finnish) chromosomes by the Genome Aggregation Database (http://gnomad.broadinstitute.org), which is a low enough frequency to award PM2_Supporting based on the thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive Usher syndrome (PM2_Supporting). The p.Asn346His variant in USH2A has been reported to segregate with hearing loss in at least 7 families including 13 family members (PP1_S; 10729113, 15241801, 17405132, 25521520, 24160897, 22135276). This variant has been detected in patients with hearing loss in trans with at least 4 pathogenic or suspected-pathogenic variants (PM3_VS; PMID: 15241801, 24160897, 22135276, 26969326). At least one patient with a variant in this gene displayed features of mild to severe hearing loss and retinitis pigmentosa (PP4; PMID: 10729113, 15241801, 17405132, 25521520, 24160897, 22135276). Computational prediction tools and conservation analysis suggest that the p.Asn346His variant may impact the protein (PP3). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Usher syndrome based on the ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: PM2_Supporting, PP1_S, PM3_VS, PP4, PP3.\",\n    \"evidenceLine\": [\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000325\",\n                            \"label\": \"Benign Stand Alone\"\n                        },\n                        \"id\": \"SEPIO-CG:99038\",\n                        \"label\": \"BA1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"I agree. Variant is present in  (20/126318) ) 0.00015% Europeans in gnomAD.\\n-MD\",\n                    \"id\": \"/evaluations/a2cd45f1-d5e9-43aa-9642-b80b34941b72/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": {\n                        \"id\": \"ClinVar:48347\",\n                        \"label\": \"NM_206933.2(USH2A):c.1036A>C (p.Asn346His)\",\n                        \"relatedContextualAllele\": [\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NC_000001.11:g.216325412T>G\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"genomic\",\n                                \"referenceGenome\": {\n                                    \"id\": \"SEPIO-CG:98203\",\n                                    \"label\": \"GRCh38\"\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:48347\",\n                                \"relatedChromosome\": {\n                                    \"id\": \"SEPIO-CG:98101\",\n                                    \"label\": \"1\"\n                                },\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NC_000001.10:g.216498754T>G\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"genomic\",\n                                \"referenceGenome\": {\n                                    \"id\": \"SEPIO-CG:98202\",\n                                    \"label\": \"GRCh37\"\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:48347\",\n                                \"relatedChromosome\": {\n                                    \"id\": \"SEPIO-CG:98101\",\n                                    \"label\": \"1\"\n                                },\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NG_009497.1:g.102985A>C\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"genomic\",\n                                \"relatedCanonicalAllele\": \"ClinVar:48347\",\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NM_206933.2:c.1036A>C\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"transcript\",\n                                \"preferred\": true,\n                                \"relatedCanonicalAllele\": \"ClinVar:48347\",\n                                \"relatedGene\": {\n                                    \"id\": \"_:b3\",\n                                    \"label\": \"USH2A\"\n                                },\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NP_996816.2:p.Asn346His\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"protein\",\n                                \"relatedCanonicalAllele\": \"ClinVar:48347\",\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"O75445:p.Asn346His\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"relatedCanonicalAllele\": \"ClinVar:48347\",\n                                \"type\": \"ContextualAllele\"\n                            }\n                        ],\n                        \"relatedIdentifier\": [\n                            {\n                                \"label\": \"NM_206933.2(USH2A):c.1036A>C (p.Asn346His)\"\n                            }\n                        ],\n                        \"type\": \"CanonicalAllele\"\n                    }\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000325\",\n            \"id\": \"_:b5\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99028\",\n                        \"label\": \"PM2\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"I agree. Variant is present in  (20/126318) ) 0.00015% Europeans in gnomAD.\\n-MD\",\n                    \"id\": \"/evaluations/b7623af6-b5c3-4f09-a08f-103b2a46b8dd/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": {\n                \"id\": \"SEPIO:0000329\",\n                \"label\": \"Pathogenic Supporting\"\n            },\n            \"id\": \"_:b6\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000328\",\n                            \"label\": \"Benign Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99039\",\n                        \"label\": \"BS1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"I agree. Variant is present in  (20/126318) ) 0.00015% Europeans in gnomAD.\\n-MD\",\n                    \"id\": \"/evaluations/85b8e2e9-5aad-44b3-a9cc-9b0e27987331/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000328\",\n            \"id\": \"_:b7\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000328\",\n                            \"label\": \"Benign Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99040\",\n                        \"label\": \"BS2\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/1edcc517-50d4-4b20-bc7e-0efc2882911c/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000328\",\n            \"id\": \"_:b8\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000330\",\n                            \"label\": \"Pathogenic Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99026\",\n                        \"label\": \"PS4\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/bc8e748d-15c8-48e2-b221-e8cea7e73cab/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000330\",\n            \"id\": \"_:b9\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000328\",\n                            \"label\": \"Benign Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99042\",\n                        \"label\": \"BS4\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"evidenceLine\": [\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"Four compound hets reported; variants on remaining allele were Thr4439Ile, Glu3305fs, Trp3521Arg, Cys419Phe.  One individual was het only.\",\n                                    \"id\": \"_:b31\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/22135276\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b33\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"1 compound het proband with Arg1295X on remaining allele.  Variants segregated in 3 affected relatives. 1 homozygous proband, variant segregated in 2 affected relatives.\",\n                                    \"id\": \"_:b34\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/24160897\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b36\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"Two siblings were cmp het for this variant and Thr4439Ile.  The brother had Usher syndrome.  The 43 year old sister had hearing loss and a slightly abnormal finding on ERG, but was otherwise normal.\",\n                                    \"id\": \"_:b37\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/25521520\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b39\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"Asn346His variant was identified in 1 proband with USH2, compound heterozygous with Gly4403fs variant\",\n                                    \"id\": \"_:b54\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/17405132\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b56\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"The Asn346His variant was identified in 1 proband in combination with a second loss of function allele c.1227G>A (p.Trp409X)\",\n                                    \"id\": \"_:b57\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/15241801\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b59\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"The Asn346His variant was identified in 2 probands with USH2. It was observed in a large Swedish family with Arg1295X, but the two variants were not present in the same individuals.  In an American family, it was compound heterozygous with another pathogenic variant 2299delG (Glu767fs).  The cDNA coordinate (c.1042A>C = p.348) in this paper was wrong, but the alignment figure showed the variant matching N346H.\",\n                                    \"id\": \"_:b60\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/10729113\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b62\",\n                            \"type\": \"EvidenceLine\"\n                        }\n                    ],\n                    \"id\": \"/evaluations/55882ace-6ca2-4068-bd27-7b16bec70888/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000328\",\n            \"id\": \"_:b10\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000329\",\n                            \"label\": \"Pathogenic Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99033\",\n                        \"label\": \"PP1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"Cosegretation with the phenotype were observed in at least 7 families including 13 affected members.\\n\\nAgree with this code usage. MD\",\n                    \"evidenceLine\": [\n                        {\n                            \"evidenceItem\": [\n                                \"_:b31\"\n                            ],\n                            \"id\": \"_:b32\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b34\"\n                            ],\n                            \"id\": \"_:b35\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b37\"\n                            ],\n                            \"id\": \"_:b38\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b54\"\n                            ],\n                            \"id\": \"_:b55\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b57\"\n                            ],\n                            \"id\": \"_:b58\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b60\"\n                            ],\n                            \"id\": \"_:b61\",\n                            \"type\": \"EvidenceLine\"\n                        }\n                    ],\n                    \"id\": \"/evaluations/c1ce28e6-2a1c-4e78-84ad-419de7f1eb02/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": {\n                \"id\": \"SEPIO:0000330\",\n                \"label\": \"Pathogenic Strong\"\n            },\n            \"id\": \"_:b11\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99032\",\n                        \"label\": \"PM6\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/fa3dbabe-7b32-4b0c-a338-25120d2982b8/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000216\",\n            \"id\": \"_:b12\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000330\",\n                            \"label\": \"Pathogenic Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99024\",\n                        \"label\": \"PS2\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/a72adc45-aba1-4872-92bb-fa3388ddf501/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000330\",\n            \"id\": \"_:b13\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000327\",\n                            \"label\": \"Benign Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99044\",\n                        \"label\": \"BP2\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"evidenceLine\": [\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"detected in trans with c.2299del\",\n                                    \"id\": \"_:b40\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/26969326\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b42\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"detected in trans with p.Glu3305ArgfsX41, p.Trp3521Arg, and Lys419Phe\",\n                                    \"id\": \"_:b45\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/22135276\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b47\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"detected in trans with p.R1295X\",\n                                    \"id\": \"_:b48\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/24160897\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b50\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"detected in trans with p.Trp409X\",\n                                    \"id\": \"_:b51\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/15241801\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b53\",\n                            \"type\": \"EvidenceLine\"\n                        }\n                    ],\n                    \"id\": \"/evaluations/4b104912-7a78-4f01-98ae-def97ac05594/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000327\",\n            \"id\": \"_:b14\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99029\",\n                        \"label\": \"PM3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"This could actually be upgraded to PM3_very strong. There are >4 cases of this variant being identified in trans with a known pathogenic variant. I've added more publications below.\\n\\n-MD\",\n                    \"evidenceLine\": [\n                        {\n                            \"evidenceItem\": [\n                                \"_:b40\"\n                            ],\n                            \"id\": \"_:b41\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b45\"\n                            ],\n                            \"id\": \"_:b46\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b48\"\n                            ],\n                            \"id\": \"_:b49\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b51\"\n                            ],\n                            \"id\": \"_:b52\",\n                            \"type\": \"EvidenceLine\"\n                        }\n                    ],\n                    \"id\": \"/evaluations/74f4097a-0051-431c-9505-9a8e98cbc9ce/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": {\n                \"id\": \"SEPIO:0000220\",\n                \"label\": \"Pathogenic Very Strong\"\n            },\n            \"id\": \"_:b15\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000327\",\n                            \"label\": \"Benign Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99047\",\n                        \"label\": \"BP5\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/cd4f9c90-58c3-436c-934e-df54a3c0e20c/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000327\",\n            \"id\": \"_:b16\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000329\",\n                            \"label\": \"Pathogenic Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99036\",\n                        \"label\": \"PP4\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"The patiens of compound heterozygotes or homozygotes with the mutation showed retinitis pigmentosa with hearing loss.\\n\\nEnough patients were also tested for the other Usher syndrome genes and found to be negative for changes in them.  I also agree.\\n-MD\",\n                    \"evidenceLine\": [\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"Usher syndrome type II\",\n                                    \"id\": \"_:b43\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/22135276\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b44\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"The Asn346His variant was identified in 2 probands with USH2. It was observed in a large Swedish family with Arg1295X, but the two variants were not present in the same individuals. In an American family, it was compound heterozygous with another pathogenic variant 2299delG (Glu767fs). The cDNA coordinate (c.1042A>C = p.348) in this paper was wrong, but the alignment figure showed the variant matching N346H.\",\n                                    \"id\": \"_:b63\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/10729113\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b64\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"The Asn346His variant was identified in 1 proband in combination with a second loss of function allele c.1227G>A (p.Trp409X).\",\n                                    \"id\": \"_:b65\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/15241801\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b66\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"Asn346His variant was identified in 1 proband with USH2, compound heterozygous with Gly4403fs variant\",\n                                    \"id\": \"_:b67\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/17405132\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b68\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"Two siblings were cmp het for this variant and Thr4439Ile. The brother had Usher syndrome. The 43 year old sister had hearing loss and a slightly abnormal finding on ERG, but was otherwise normal.\",\n                                    \"id\": \"_:b69\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/25521520\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b70\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"1 compound het proband with Arg1295X on remaining allele. Variants segregated in 3 affected relatives. 1 homozygous proband, variant segregated in 2 affected relatives.\",\n                                    \"id\": \"_:b71\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/24160897\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b72\",\n                            \"type\": \"EvidenceLine\"\n                        }\n                    ],\n                    \"id\": \"/evaluations/93b99d41-836a-44bc-8088-bdd838589371/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000329\",\n            \"id\": \"_:b17\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000329\",\n                            \"label\": \"Pathogenic Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99035\",\n                        \"label\": \"PP3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"Agree. REVEL is >0.7\\n-MD\",\n                    \"id\": \"/evaluations/5616e6d5-7f86-49e3-9ea1-71a7b773159d/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000329\",\n            \"id\": \"_:b18\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000327\",\n                            \"label\": \"Benign Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99046\",\n                        \"label\": \"BP4\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"Agree. REVEL is >0.7\\n-MD\",\n                    \"id\": \"/evaluations/f9cfb2d3-3d20-4504-a578-2871af8999b0/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000327\",\n            \"id\": \"_:b19\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000327\",\n                            \"label\": \"Benign Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99043\",\n                        \"label\": \"BP1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/ceb68047-e012-4980-a5b0-801789bea53b/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000327\",\n            \"id\": \"_:b20\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000329\",\n                            \"label\": \"Pathogenic Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99034\",\n                        \"label\": \"PP2\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/8edae42e-aab1-484b-a896-c718fc723b30/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000329\",\n            \"id\": \"_:b21\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99031\",\n                        \"label\": \"PM5\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/662f5c10-c6b5-4fed-8f33-278d242dfc13/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000216\",\n            \"id\": \"_:b22\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000330\",\n                            \"label\": \"Pathogenic Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99023\",\n                        \"label\": \"PS1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/abdafc0b-a024-4ca4-869e-e40fa6026ae7/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000330\",\n            \"id\": \"_:b23\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99027\",\n                        \"label\": \"PM1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/7ea52d4f-c4ad-4193-b095-f4dc782ca82b/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000216\",\n            \"id\": \"_:b24\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000328\",\n                            \"label\": \"Benign Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99041\",\n                        \"label\": \"BS3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/bc446b22-1440-4156-b8a2-1a106c9de860/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000328\",\n            \"id\": \"_:b25\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000330\",\n                            \"label\": \"Pathogenic Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99025\",\n                        \"label\": \"PS3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/cf6f6da6-e3dd-47f9-bed2-6b662bb998fe/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000330\",\n            \"id\": \"_:b26\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000220\",\n                            \"label\": \"Pathogenic Very Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99022\",\n                        \"label\": \"PVS1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/38027f88-5a5b-4b55-846d-095c5fa52b48/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000220\",\n            \"id\": \"_:b27\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000327\",\n                            \"label\": \"Benign Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99049\",\n                        \"label\": \"BP7\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/885294a6-ffe8-4565-923d-15fa65dfed3b/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000327\",\n            \"id\": \"_:b28\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000327\",\n                            \"label\": \"Benign Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99045\",\n                        \"label\": \"BP3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/47bdc345-4ff6-4c97-ae15-14ba734633ba/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000327\",\n            \"id\": \"_:b29\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99030\",\n                        \"label\": \"PM4\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/b83e3b5b-1079-48c9-9a07-7f817632ec34/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000216\",\n            \"id\": \"_:b30\",\n            \"type\": \"EvidenceLine\"\n        }\n    ],\n    \"id\": \"https://vci.clinicalgenome.org/interpretations/211c3a9c-3789-42d9-ab55-04892c95f534/\",\n    \"statementOutcome\": {\n        \"id\": \"LOINC:LA6668-3\",\n        \"label\": \"Pathogenic\"\n    },\n    \"type\": \"VariantPathogenicityInterpretation\",\n    \"variant\": \"ClinVar:48347\"\n},\n{\n    \"@context\": \"http://dataexchange.clinicalgenome.org/interpretation/json/context\",\n    \"assertionMethod\": {\n        \"label\": \"Hearing Loss ACMG Specifications v1 2018\",\n        \"type\": \"VariantPathogenicityInterpretationGuideline\",\n        \"url\": \"https://submit.ncbi.nlm.nih.gov/ft/byid/vroiax8b/hearing_loss_acmg_specifications_v1_2018.pdf\"\n    },\n    \"condition\": [\n        {\n            \"disease\": [\n                {\n                    \"id\": \"MONDO:0019497\",\n                    \"label\": \"nonsyndromic genetic deafness\"\n                }\n            ],\n            \"inheritancePattern\": {\n                \"id\": \"HP:0000007\",\n                \"label\": \"Autosomal recessive inheritance\"\n            },\n            \"type\": \"GeneticCondition\"\n        }\n    ],\n    \"contribution\": [\n        {\n            \"agent\": {\n                \"id\": \"http://curation.clinicalgenome.org/affiliation/10007\",\n                \"label\": \"ClinGen Hearing Loss Expert Panel\",\n                \"type\": \"Agent\"\n            },\n            \"contributionDate\": \"2018-09-14T16:00:00.000Z\",\n            \"contributionRole\": {\n                \"id\": \"SEPIO:0000155\",\n                \"label\": \"approver\"\n            },\n            \"type\": \"Contribution\"\n        },\n        {\n            \"agent\": \"http://curation.clinicalgenome.org/affiliation/10007\",\n            \"contributionDate\": \"2018-12-10T00:00:00\",\n            \"contributionRole\": {\n                \"id\": \"SEPIO-CG:97010\",\n                \"label\": \"publisher\"\n            },\n            \"type\": \"Contribution\"\n        }\n    ],\n    \"description\": \"The filtering allele frequency of the p.Leu79CysfsX3 variant in the GJB2 gene is 0.55% (121/ 18870) of East Asian chromosomes by the Genome Aggregation Database (http://gnomad.broadinstitute.org; calculated by using inverse allele frequency at https://www.cardiodb.org/allelefrequencyapp/), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive hearing loss variants (BS1). The ClinGen Hearing Loss Expert Panel believes that the evidence for the pathogenicity of this variant for nonsyndromic hearing loss outweighs the high allele frequency of the variant in population databases. Therefore, the BS1 code will not contribute to the overall classification. The p.Leu79CysfsX3 variant in GJB2 is predicted to cause a premature stop codon in the only exon of the gene, leading to absent protein in a gene in which loss-of-function is an established mechanism (PVS1). This variant has been detected in patients with hearing loss in trans with at least 4 pathogenic or suspected-pathogenic variants (PM3_VS; PMID: 10983956, 10633133). A dye transfer assay, a functional study, has shown that the variant impacts protein function (PS3_M; PMID: 12352684). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive nonsyndromic hearing loss based on the ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: PVS1, PM3_VS, PS3_M, BS1.\",\n    \"evidenceLine\": [\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000325\",\n                            \"label\": \"Benign Stand Alone\"\n                        },\n                        \"id\": \"SEPIO-CG:99038\",\n                        \"label\": \"BA1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"Although the MAF (using the ExAC FAF) is .38% in  East Asians, BS1 is not contributing to the overall pathogenicity because this variant is on the HL ClinGen CDWG exclusion list.\",\n                    \"id\": \"/evaluations/50f2407d-286d-48a4-a753-71d6e67450cd/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": {\n                        \"id\": \"ClinVar:17014\",\n                        \"label\": \"NM_004004.5(GJB2):c.235delC (p.Leu79Cysfs)\",\n                        \"relatedContextualAllele\": [\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NC_000013.11:g.20189347delG\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"genomic\",\n                                \"referenceCoordinate\": {\n                                    \"end\": {\n                                        \"index\": 20189347\n                                    },\n                                    \"refState\": \"G\",\n                                    \"referenceSequence\": {\n                                        \"label\": \"NC_000013.11\"\n                                    },\n                                    \"start\": {\n                                        \"index\": 20189346\n                                    }\n                                },\n                                \"referenceGenome\": {\n                                    \"id\": \"SEPIO-CG:98203\",\n                                    \"label\": \"GRCh38\"\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:17014\",\n                                \"relatedChromosome\": {\n                                    \"id\": \"SEPIO-CG:98113\",\n                                    \"label\": \"13\"\n                                },\n                                \"state\": \"\",\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NC_000013.10:g.20763486del\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"genomic\",\n                                \"referenceCoordinate\": {\n                                    \"referenceSequence\": {\n                                        \"label\": \"NC_000013.10\"\n                                    }\n                                },\n                                \"referenceGenome\": {\n                                    \"id\": \"SEPIO-CG:98202\",\n                                    \"label\": \"GRCh37\"\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:17014\",\n                                \"relatedChromosome\": {\n                                    \"id\": \"SEPIO-CG:98113\",\n                                    \"label\": \"13\"\n                                },\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NG_008358.1:g.8629delC\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"genomic\",\n                                \"referenceCoordinate\": {\n                                    \"end\": {\n                                        \"index\": 8627\n                                    },\n                                    \"refState\": \"C\",\n                                    \"referenceSequence\": {\n                                        \"label\": \"NG_008358.1\"\n                                    },\n                                    \"start\": {\n                                        \"index\": 8626\n                                    }\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:17014\",\n                                \"state\": \"\",\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NM_004004.5:c.235delC\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"transcript\",\n                                \"preferred\": true,\n                                \"referenceCoordinate\": {\n                                    \"end\": {\n                                        \"index\": 448\n                                    },\n                                    \"refState\": \"C\",\n                                    \"referenceSequence\": {\n                                        \"label\": \"NM_004004.5\"\n                                    },\n                                    \"start\": {\n                                        \"index\": 447\n                                    }\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:17014\",\n                                \"relatedGene\": {\n                                    \"id\": \"NCBIGene:2706\",\n                                    \"label\": \"GJB2\"\n                                },\n                                \"state\": \"\",\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NP_003995.2:p.Leu79Cysfs\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"protein\",\n                                \"referenceCoordinate\": {\n                                    \"referenceSequence\": {\n                                        \"label\": \"NP_003995.2\"\n                                    }\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:17014\",\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NM_004004.5:c.235del\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"transcript\",\n                                \"preferred\": true,\n                                \"referenceCoordinate\": {\n                                    \"end\": {\n                                        \"index\": 448\n                                    },\n                                    \"refState\": \"C\",\n                                    \"referenceSequence\": {\n                                        \"label\": \"NM_004004.5\"\n                                    },\n                                    \"start\": {\n                                        \"index\": 447\n                                    }\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:17014\",\n                                \"relatedGene\": {\n                                    \"id\": \"NCBIGene:2706\",\n                                    \"label\": \"GJB2\"\n                                },\n                                \"state\": \"\",\n                                \"type\": \"ContextualAllele\"\n                            }\n                        ],\n                        \"relatedIdentifier\": [\n                            {\n                                \"id\": \"http://reg.genome.network/allele/CA127025\",\n                                \"label\": \"NM_004004.5(GJB2):c.235delC (p.Leu79Cysfs)\"\n                            },\n                            {\n                                \"id\": \"dbSNP:80338943\"\n                            }\n                        ],\n                        \"type\": \"CanonicalAllele\"\n                    }\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000325\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99028\",\n                        \"label\": \"PM2\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"Although the MAF (using the ExAC FAF) is .38% in  East Asians, BS1 is not contributing to the overall pathogenicity because this variant is on the HL ClinGen CDWG exclusion list.\",\n                    \"id\": \"/evaluations/3d6edcc8-d327-4a4d-ae41-3351707ac4dc/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:17014\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000216\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000328\",\n                            \"label\": \"Benign Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99039\",\n                        \"label\": \"BS1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"Although the MAF (using the ExAC FAF) is .38% in  East Asians, BS1 is not contributing to the overall pathogenicity because this variant is on the HL ClinGen CDWG exclusion list.\",\n                    \"id\": \"/evaluations/27fc6087-dfc3-4a06-94cb-ce5f72cfa29e/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:17014\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000328\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000329\",\n                            \"label\": \"Pathogenic Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99035\",\n                        \"label\": \"PP3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"No splicing change predicted by MaxEntScan.\",\n                    \"id\": \"/evaluations/d5a5c7f5-2bd5-469b-ab14-fccb4dab0f6b/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:17014\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000329\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000220\",\n                            \"label\": \"Pathogenic Very Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99022\",\n                        \"label\": \"PVS1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"There are no alternate transcripts, the variant should results in NMD and lack of protein.\",\n                    \"id\": \"/evaluations/6c08885d-ce9b-4dc9-9cd9-13a1d6d773fe/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:17014\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000220\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99029\",\n                        \"label\": \"PM3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"This variant was identified in  >10 individuals with a pathogenic variant in trans. See the individuals publication notes below for case counts.\",\n                    \"evidenceLine\": [\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"This is a mutation analysis for Japanese non-syndromic hearing loss. The c.235delC variant was identified in 7 affected families. Two families were homozygous, three families were compound het for Y136X, and two families were compound het for R143W.\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/10633133\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"147 Korean patients with NSHL were screened for variants in GJB2. The c.235delC variant was identifed in 5 homozygous individuals and 5 compound hets. Because the het individuals did not have a second variant listed, I would only count the homozygous individuals here.\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/10983956\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"type\": \"EvidenceLine\"\n                        }\n                    ],\n                    \"id\": \"/evaluations/e02f03be-2aa4-4ffd-b061-38c8a4a02b47/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:17014\"\n                }\n            ],\n            \"evidenceStrength\": {\n                \"id\": \"SEPIO:0000220\",\n                \"label\": \"Pathogenic Very Strong\"\n            },\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000330\",\n                            \"label\": \"Pathogenic Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99025\",\n                        \"label\": \"PS3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"A dye transfer assay demonstrated that there was no dye transfer in cells transfected with the c.235delC variant.\",\n                    \"evidenceLine\": [\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"HeLa cells were transfected with WT, mock transfected cells, or c.235delC constructs. Lucifer yellow was incubated with the cells for the dye transfer assay. Cells with the WT GJB2 demonstrated dye transfer, the negative control and the c.235delC cells had no dye transfer.\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/12352684\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"type\": \"EvidenceLine\"\n                        }\n                    ],\n                    \"id\": \"/evaluations/73bbb907-7d42-468c-adff-a73b3cf468a9/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:17014\"\n                }\n            ],\n            \"evidenceStrength\": {\n                \"id\": \"SEPIO:0000216\",\n                \"label\": \"Pathogenic Moderate\"\n            },\n            \"type\": \"EvidenceLine\"\n        }\n    ],\n    \"id\": \"https://vci.clinicalgenome.org/interpretations/eda5030c-9ccf-4b14-bada-077b25b2562c/\",\n    \"statementOutcome\": {\n        \"id\": \"LOINC:LA6668-3\",\n        \"label\": \"Pathogenic\"\n    },\n    \"type\": \"VariantPathogenicityInterpretation\",\n    \"variant\": \"ClinVar:17014\"\n}]"
				},
				"url": {
					"raw": "http://35.196.45.74/api/v1/submission",
					"protocol": "http",
					"host": [
						"35",
						"196",
						"45",
						"74"
					],
					"path": [
						"api",
						"v1",
						"submission"
					]
				}
			},
			"response": []
		},
		{
			"name": "Bad URL",
			"request": {
				"method": "POST",
				"header": [
					{
						"key": "Content-Type",
						"name": "Content-Type",
						"type": "text",
						"value": "application/json"
					}
				],
				"body": {
					"mode": "raw",
					"raw": "[{\n    \"@context\": \"http://dataexchange.clinicalgenome.org/interpretation/json/context\",\n    \"assertionMethod\": {\n        \"id\": \"_:b0\",\n        \"label\": \"Hearing Loss ACMG Specifications v1 2018\",\n        \"type\": \"VariantPathogenicityInterpretationGuideline\",\n        \"url\": \"https://submit.ncbi.nlm.nih.gov/ft/byid/vroiax8b/hearing_loss_acmg_specifications_v1_2018.pdf\"\n    },\n    \"condition\": [\n        {\n            \"phenotype\": [\n                {\n                    \"id\": \"HP:0000001\"\n                },\n                {\n                    \"id\": \"HP:0000002\"\n                }\n            ],\n            \"id\": \"_:b4\",\n            \"inheritancePattern\": {\n                \"id\": \"HP:0000007\",\n                \"label\": \"Autosomal recessive inheritance\"\n            },\n            \"type\": \"GeneticCondition\"\n        }\n    ],\n    \"contribution\": [\n        {\n            \"agent\": {\n                \"id\": \"http://curation.clinicalgenome.org/affiliation/10007\",\n                \"label\": \"ClinGen Hearing Loss Expert Panel\",\n                \"type\": \"Agent\"\n            },\n            \"contributionRole\": {\n                \"id\": \"SEPIO:0000155\",\n                \"label\": \"approver\"\n            },\n            \"id\": \"_:b1\",\n            \"type\": \"Contribution\"\n        },\n        {\n            \"agent\": \"http://curation.clinicalgenome.org/affiliation/10007\",\n            \"contributionDate\": \"2018-10-02T00:00:00\",\n            \"contributionRole\": {\n                \"id\": \"SEPIO-CG:97010\",\n                \"label\": \"publisher\"\n            },\n            \"id\": \"_:b2\",\n            \"type\": \"Contribution\"\n        }\n    ],\n    \"description\": \"The allele frequency of the p.Asn346His variant in the USH2A gene is 0.016% (20/126318) of European (Non-Finnish) chromosomes by the Genome Aggregation Database (http://gnomad.broadinstitute.org), which is a low enough frequency to award PM2_Supporting based on the thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive Usher syndrome (PM2_Supporting). The p.Asn346His variant in USH2A has been reported to segregate with hearing loss in at least 7 families including 13 family members (PP1_S; 10729113, 15241801, 17405132, 25521520, 24160897, 22135276). This variant has been detected in patients with hearing loss in trans with at least 4 pathogenic or suspected-pathogenic variants (PM3_VS; PMID: 15241801, 24160897, 22135276, 26969326). At least one patient with a variant in this gene displayed features of mild to severe hearing loss and retinitis pigmentosa (PP4; PMID: 10729113, 15241801, 17405132, 25521520, 24160897, 22135276). Computational prediction tools and conservation analysis suggest that the p.Asn346His variant may impact the protein (PP3). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Usher syndrome based on the ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: PM2_Supporting, PP1_S, PM3_VS, PP4, PP3.\",\n    \"evidenceLine\": [\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000325\",\n                            \"label\": \"Benign Stand Alone\"\n                        },\n                        \"id\": \"SEPIO-CG:99038\",\n                        \"label\": \"BA1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"I agree. Variant is present in  (20/126318) ) 0.00015% Europeans in gnomAD.\\n-MD\",\n                    \"id\": \"/evaluations/a2cd45f1-d5e9-43aa-9642-b80b34941b72/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": {\n                        \"id\": \"ClinVar:48347\",\n                        \"label\": \"NM_206933.2(USH2A):c.1036A>C (p.Asn346His)\",\n                        \"relatedContextualAllele\": [\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NC_000001.11:g.216325412T>G\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"genomic\",\n                                \"referenceGenome\": {\n                                    \"id\": \"SEPIO-CG:98203\",\n                                    \"label\": \"GRCh38\"\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:48347\",\n                                \"relatedChromosome\": {\n                                    \"id\": \"SEPIO-CG:98101\",\n                                    \"label\": \"1\"\n                                },\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NC_000001.10:g.216498754T>G\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"genomic\",\n                                \"referenceGenome\": {\n                                    \"id\": \"SEPIO-CG:98202\",\n                                    \"label\": \"GRCh37\"\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:48347\",\n                                \"relatedChromosome\": {\n                                    \"id\": \"SEPIO-CG:98101\",\n                                    \"label\": \"1\"\n                                },\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NG_009497.1:g.102985A>C\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"genomic\",\n                                \"relatedCanonicalAllele\": \"ClinVar:48347\",\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NM_206933.2:c.1036A>C\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"transcript\",\n                                \"preferred\": true,\n                                \"relatedCanonicalAllele\": \"ClinVar:48347\",\n                                \"relatedGene\": {\n                                    \"id\": \"_:b3\",\n                                    \"label\": \"USH2A\"\n                                },\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NP_996816.2:p.Asn346His\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"protein\",\n                                \"relatedCanonicalAllele\": \"ClinVar:48347\",\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"O75445:p.Asn346His\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"relatedCanonicalAllele\": \"ClinVar:48347\",\n                                \"type\": \"ContextualAllele\"\n                            }\n                        ],\n                        \"relatedIdentifier\": [\n                            {\n                                \"label\": \"NM_206933.2(USH2A):c.1036A>C (p.Asn346His)\"\n                            }\n                        ],\n                        \"type\": \"CanonicalAllele\"\n                    }\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000325\",\n            \"id\": \"_:b5\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99028\",\n                        \"label\": \"PM2\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"I agree. Variant is present in  (20/126318) ) 0.00015% Europeans in gnomAD.\\n-MD\",\n                    \"id\": \"/evaluations/b7623af6-b5c3-4f09-a08f-103b2a46b8dd/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": {\n                \"id\": \"SEPIO:0000329\",\n                \"label\": \"Pathogenic Supporting\"\n            },\n            \"id\": \"_:b6\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000328\",\n                            \"label\": \"Benign Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99039\",\n                        \"label\": \"BS1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"I agree. Variant is present in  (20/126318) ) 0.00015% Europeans in gnomAD.\\n-MD\",\n                    \"id\": \"/evaluations/85b8e2e9-5aad-44b3-a9cc-9b0e27987331/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000328\",\n            \"id\": \"_:b7\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000328\",\n                            \"label\": \"Benign Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99040\",\n                        \"label\": \"BS2\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/1edcc517-50d4-4b20-bc7e-0efc2882911c/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000328\",\n            \"id\": \"_:b8\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000330\",\n                            \"label\": \"Pathogenic Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99026\",\n                        \"label\": \"PS4\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/bc8e748d-15c8-48e2-b221-e8cea7e73cab/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000330\",\n            \"id\": \"_:b9\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000328\",\n                            \"label\": \"Benign Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99042\",\n                        \"label\": \"BS4\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"evidenceLine\": [\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"Four compound hets reported; variants on remaining allele were Thr4439Ile, Glu3305fs, Trp3521Arg, Cys419Phe.  One individual was het only.\",\n                                    \"id\": \"_:b31\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/22135276\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b33\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"1 compound het proband with Arg1295X on remaining allele.  Variants segregated in 3 affected relatives. 1 homozygous proband, variant segregated in 2 affected relatives.\",\n                                    \"id\": \"_:b34\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/24160897\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b36\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"Two siblings were cmp het for this variant and Thr4439Ile.  The brother had Usher syndrome.  The 43 year old sister had hearing loss and a slightly abnormal finding on ERG, but was otherwise normal.\",\n                                    \"id\": \"_:b37\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/25521520\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b39\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"Asn346His variant was identified in 1 proband with USH2, compound heterozygous with Gly4403fs variant\",\n                                    \"id\": \"_:b54\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/17405132\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b56\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"The Asn346His variant was identified in 1 proband in combination with a second loss of function allele c.1227G>A (p.Trp409X)\",\n                                    \"id\": \"_:b57\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/15241801\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b59\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"The Asn346His variant was identified in 2 probands with USH2. It was observed in a large Swedish family with Arg1295X, but the two variants were not present in the same individuals.  In an American family, it was compound heterozygous with another pathogenic variant 2299delG (Glu767fs).  The cDNA coordinate (c.1042A>C = p.348) in this paper was wrong, but the alignment figure showed the variant matching N346H.\",\n                                    \"id\": \"_:b60\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/10729113\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b62\",\n                            \"type\": \"EvidenceLine\"\n                        }\n                    ],\n                    \"id\": \"/evaluations/55882ace-6ca2-4068-bd27-7b16bec70888/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000328\",\n            \"id\": \"_:b10\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000329\",\n                            \"label\": \"Pathogenic Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99033\",\n                        \"label\": \"PP1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"Cosegretation with the phenotype were observed in at least 7 families including 13 affected members.\\n\\nAgree with this code usage. MD\",\n                    \"evidenceLine\": [\n                        {\n                            \"evidenceItem\": [\n                                \"_:b31\"\n                            ],\n                            \"id\": \"_:b32\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b34\"\n                            ],\n                            \"id\": \"_:b35\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b37\"\n                            ],\n                            \"id\": \"_:b38\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b54\"\n                            ],\n                            \"id\": \"_:b55\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b57\"\n                            ],\n                            \"id\": \"_:b58\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b60\"\n                            ],\n                            \"id\": \"_:b61\",\n                            \"type\": \"EvidenceLine\"\n                        }\n                    ],\n                    \"id\": \"/evaluations/c1ce28e6-2a1c-4e78-84ad-419de7f1eb02/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": {\n                \"id\": \"SEPIO:0000330\",\n                \"label\": \"Pathogenic Strong\"\n            },\n            \"id\": \"_:b11\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99032\",\n                        \"label\": \"PM6\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/fa3dbabe-7b32-4b0c-a338-25120d2982b8/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000216\",\n            \"id\": \"_:b12\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000330\",\n                            \"label\": \"Pathogenic Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99024\",\n                        \"label\": \"PS2\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/a72adc45-aba1-4872-92bb-fa3388ddf501/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000330\",\n            \"id\": \"_:b13\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000327\",\n                            \"label\": \"Benign Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99044\",\n                        \"label\": \"BP2\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"evidenceLine\": [\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"detected in trans with c.2299del\",\n                                    \"id\": \"_:b40\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/26969326\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b42\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"detected in trans with p.Glu3305ArgfsX41, p.Trp3521Arg, and Lys419Phe\",\n                                    \"id\": \"_:b45\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/22135276\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b47\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"detected in trans with p.R1295X\",\n                                    \"id\": \"_:b48\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/24160897\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b50\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"detected in trans with p.Trp409X\",\n                                    \"id\": \"_:b51\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/15241801\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b53\",\n                            \"type\": \"EvidenceLine\"\n                        }\n                    ],\n                    \"id\": \"/evaluations/4b104912-7a78-4f01-98ae-def97ac05594/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000327\",\n            \"id\": \"_:b14\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99029\",\n                        \"label\": \"PM3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"This could actually be upgraded to PM3_very strong. There are >4 cases of this variant being identified in trans with a known pathogenic variant. I've added more publications below.\\n\\n-MD\",\n                    \"evidenceLine\": [\n                        {\n                            \"evidenceItem\": [\n                                \"_:b40\"\n                            ],\n                            \"id\": \"_:b41\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b45\"\n                            ],\n                            \"id\": \"_:b46\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b48\"\n                            ],\n                            \"id\": \"_:b49\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                \"_:b51\"\n                            ],\n                            \"id\": \"_:b52\",\n                            \"type\": \"EvidenceLine\"\n                        }\n                    ],\n                    \"id\": \"/evaluations/74f4097a-0051-431c-9505-9a8e98cbc9ce/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": {\n                \"id\": \"SEPIO:0000220\",\n                \"label\": \"Pathogenic Very Strong\"\n            },\n            \"id\": \"_:b15\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000327\",\n                            \"label\": \"Benign Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99047\",\n                        \"label\": \"BP5\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/cd4f9c90-58c3-436c-934e-df54a3c0e20c/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000327\",\n            \"id\": \"_:b16\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000329\",\n                            \"label\": \"Pathogenic Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99036\",\n                        \"label\": \"PP4\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"The patiens of compound heterozygotes or homozygotes with the mutation showed retinitis pigmentosa with hearing loss.\\n\\nEnough patients were also tested for the other Usher syndrome genes and found to be negative for changes in them.  I also agree.\\n-MD\",\n                    \"evidenceLine\": [\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"Usher syndrome type II\",\n                                    \"id\": \"_:b43\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/22135276\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b44\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"The Asn346His variant was identified in 2 probands with USH2. It was observed in a large Swedish family with Arg1295X, but the two variants were not present in the same individuals. In an American family, it was compound heterozygous with another pathogenic variant 2299delG (Glu767fs). The cDNA coordinate (c.1042A>C = p.348) in this paper was wrong, but the alignment figure showed the variant matching N346H.\",\n                                    \"id\": \"_:b63\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/10729113\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b64\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"The Asn346His variant was identified in 1 proband in combination with a second loss of function allele c.1227G>A (p.Trp409X).\",\n                                    \"id\": \"_:b65\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/15241801\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b66\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"Asn346His variant was identified in 1 proband with USH2, compound heterozygous with Gly4403fs variant\",\n                                    \"id\": \"_:b67\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/17405132\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b68\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"Two siblings were cmp het for this variant and Thr4439Ile. The brother had Usher syndrome. The 43 year old sister had hearing loss and a slightly abnormal finding on ERG, but was otherwise normal.\",\n                                    \"id\": \"_:b69\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/25521520\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b70\",\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"1 compound het proband with Arg1295X on remaining allele. Variants segregated in 3 affected relatives. 1 homozygous proband, variant segregated in 2 affected relatives.\",\n                                    \"id\": \"_:b71\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/24160897\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"id\": \"_:b72\",\n                            \"type\": \"EvidenceLine\"\n                        }\n                    ],\n                    \"id\": \"/evaluations/93b99d41-836a-44bc-8088-bdd838589371/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000329\",\n            \"id\": \"_:b17\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000329\",\n                            \"label\": \"Pathogenic Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99035\",\n                        \"label\": \"PP3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"Agree. REVEL is >0.7\\n-MD\",\n                    \"id\": \"/evaluations/5616e6d5-7f86-49e3-9ea1-71a7b773159d/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000329\",\n            \"id\": \"_:b18\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000327\",\n                            \"label\": \"Benign Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99046\",\n                        \"label\": \"BP4\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"Agree. REVEL is >0.7\\n-MD\",\n                    \"id\": \"/evaluations/f9cfb2d3-3d20-4504-a578-2871af8999b0/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000327\",\n            \"id\": \"_:b19\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000327\",\n                            \"label\": \"Benign Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99043\",\n                        \"label\": \"BP1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/ceb68047-e012-4980-a5b0-801789bea53b/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000327\",\n            \"id\": \"_:b20\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000329\",\n                            \"label\": \"Pathogenic Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99034\",\n                        \"label\": \"PP2\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/8edae42e-aab1-484b-a896-c718fc723b30/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000329\",\n            \"id\": \"_:b21\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99031\",\n                        \"label\": \"PM5\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/662f5c10-c6b5-4fed-8f33-278d242dfc13/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000216\",\n            \"id\": \"_:b22\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000330\",\n                            \"label\": \"Pathogenic Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99023\",\n                        \"label\": \"PS1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/abdafc0b-a024-4ca4-869e-e40fa6026ae7/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000330\",\n            \"id\": \"_:b23\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99027\",\n                        \"label\": \"PM1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/7ea52d4f-c4ad-4193-b095-f4dc782ca82b/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000216\",\n            \"id\": \"_:b24\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000328\",\n                            \"label\": \"Benign Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99041\",\n                        \"label\": \"BS3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/bc446b22-1440-4156-b8a2-1a106c9de860/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000328\",\n            \"id\": \"_:b25\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000330\",\n                            \"label\": \"Pathogenic Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99025\",\n                        \"label\": \"PS3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/cf6f6da6-e3dd-47f9-bed2-6b662bb998fe/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000330\",\n            \"id\": \"_:b26\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000220\",\n                            \"label\": \"Pathogenic Very Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99022\",\n                        \"label\": \"PVS1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/38027f88-5a5b-4b55-846d-095c5fa52b48/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000220\",\n            \"id\": \"_:b27\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000327\",\n                            \"label\": \"Benign Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99049\",\n                        \"label\": \"BP7\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/885294a6-ffe8-4565-923d-15fa65dfed3b/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000327\",\n            \"id\": \"_:b28\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000327\",\n                            \"label\": \"Benign Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99045\",\n                        \"label\": \"BP3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/47bdc345-4ff6-4c97-ae15-14ba734633ba/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000327\",\n            \"id\": \"_:b29\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99030\",\n                        \"label\": \"PM4\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"\",\n                    \"id\": \"/evaluations/b83e3b5b-1079-48c9-9a07-7f817632ec34/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:48347\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000216\",\n            \"id\": \"_:b30\",\n            \"type\": \"EvidenceLine\"\n        }\n    ],\n    \"id\": \"https://vci.clinicalgenome.org/interpretations/211c3a9c-3789-42d9-ab55-04892c95f534/\",\n    \"statementOutcome\": {\n        \"id\": \"LOINC:LA6668-3\",\n        \"label\": \"Pathogenic\"\n    },\n    \"type\": \"VariantPathogenicityInterpretation\",\n    \"variant\": \"ClinVar:48347\"\n},\n{\n    \"@context\": \"http://dataexchange.clinicalgenome.org/interpretation/json/context\",\n    \"assertionMethod\": {\n        \"label\": \"Hearing Loss ACMG Specifications v1 2018\",\n        \"type\": \"VariantPathogenicityInterpretationGuideline\",\n        \"url\": \"https://submit.ncbi.nlm.nih.gov/ft/byid/vroiax8b/hearing_loss_acmg_specifications_v1_2018.pdf\"\n    },\n    \"condition\": [\n        {\n            \"disease\": [\n                {\n                    \"id\": \"MONDO:0019497\",\n                    \"label\": \"nonsyndromic genetic deafness\"\n                }\n            ],\n            \"inheritancePattern\": {\n                \"id\": \"HP:0000007\",\n                \"label\": \"Autosomal recessive inheritance\"\n            },\n            \"type\": \"GeneticCondition\"\n        }\n    ],\n    \"contribution\": [\n        {\n            \"agent\": {\n                \"id\": \"http://curation.clinicalgenome.org/affiliation/10007\",\n                \"label\": \"ClinGen Hearing Loss Expert Panel\",\n                \"type\": \"Agent\"\n            },\n            \"contributionDate\": \"2018-09-14T16:00:00.000Z\",\n            \"contributionRole\": {\n                \"id\": \"SEPIO:0000155\",\n                \"label\": \"approver\"\n            },\n            \"type\": \"Contribution\"\n        },\n        {\n            \"agent\": \"http://curation.clinicalgenome.org/affiliation/10007\",\n            \"contributionDate\": \"2018-12-10T00:00:00\",\n            \"contributionRole\": {\n                \"id\": \"SEPIO-CG:97010\",\n                \"label\": \"publisher\"\n            },\n            \"type\": \"Contribution\"\n        }\n    ],\n    \"description\": \"The filtering allele frequency of the p.Leu79CysfsX3 variant in the GJB2 gene is 0.55% (121/ 18870) of East Asian chromosomes by the Genome Aggregation Database (http://gnomad.broadinstitute.org; calculated by using inverse allele frequency at https://www.cardiodb.org/allelefrequencyapp/), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive hearing loss variants (BS1). The ClinGen Hearing Loss Expert Panel believes that the evidence for the pathogenicity of this variant for nonsyndromic hearing loss outweighs the high allele frequency of the variant in population databases. Therefore, the BS1 code will not contribute to the overall classification. The p.Leu79CysfsX3 variant in GJB2 is predicted to cause a premature stop codon in the only exon of the gene, leading to absent protein in a gene in which loss-of-function is an established mechanism (PVS1). This variant has been detected in patients with hearing loss in trans with at least 4 pathogenic or suspected-pathogenic variants (PM3_VS; PMID: 10983956, 10633133). A dye transfer assay, a functional study, has shown that the variant impacts protein function (PS3_M; PMID: 12352684). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive nonsyndromic hearing loss based on the ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: PVS1, PM3_VS, PS3_M, BS1.\",\n    \"evidenceLine\": [\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000325\",\n                            \"label\": \"Benign Stand Alone\"\n                        },\n                        \"id\": \"SEPIO-CG:99038\",\n                        \"label\": \"BA1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"Although the MAF (using the ExAC FAF) is .38% in  East Asians, BS1 is not contributing to the overall pathogenicity because this variant is on the HL ClinGen CDWG exclusion list.\",\n                    \"id\": \"/evaluations/50f2407d-286d-48a4-a753-71d6e67450cd/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": {\n                        \"id\": \"ClinVar:17014\",\n                        \"label\": \"NM_004004.5(GJB2):c.235delC (p.Leu79Cysfs)\",\n                        \"relatedContextualAllele\": [\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NC_000013.11:g.20189347delG\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"genomic\",\n                                \"referenceCoordinate\": {\n                                    \"end\": {\n                                        \"index\": 20189347\n                                    },\n                                    \"refState\": \"G\",\n                                    \"referenceSequence\": {\n                                        \"label\": \"NC_000013.11\"\n                                    },\n                                    \"start\": {\n                                        \"index\": 20189346\n                                    }\n                                },\n                                \"referenceGenome\": {\n                                    \"id\": \"SEPIO-CG:98203\",\n                                    \"label\": \"GRCh38\"\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:17014\",\n                                \"relatedChromosome\": {\n                                    \"id\": \"SEPIO-CG:98113\",\n                                    \"label\": \"13\"\n                                },\n                                \"state\": \"\",\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NC_000013.10:g.20763486del\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"genomic\",\n                                \"referenceCoordinate\": {\n                                    \"referenceSequence\": {\n                                        \"label\": \"NC_000013.10\"\n                                    }\n                                },\n                                \"referenceGenome\": {\n                                    \"id\": \"SEPIO-CG:98202\",\n                                    \"label\": \"GRCh37\"\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:17014\",\n                                \"relatedChromosome\": {\n                                    \"id\": \"SEPIO-CG:98113\",\n                                    \"label\": \"13\"\n                                },\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NG_008358.1:g.8629delC\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"genomic\",\n                                \"referenceCoordinate\": {\n                                    \"end\": {\n                                        \"index\": 8627\n                                    },\n                                    \"refState\": \"C\",\n                                    \"referenceSequence\": {\n                                        \"label\": \"NG_008358.1\"\n                                    },\n                                    \"start\": {\n                                        \"index\": 8626\n                                    }\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:17014\",\n                                \"state\": \"\",\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NM_004004.5:c.235delC\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"transcript\",\n                                \"preferred\": true,\n                                \"referenceCoordinate\": {\n                                    \"end\": {\n                                        \"index\": 448\n                                    },\n                                    \"refState\": \"C\",\n                                    \"referenceSequence\": {\n                                        \"label\": \"NM_004004.5\"\n                                    },\n                                    \"start\": {\n                                        \"index\": 447\n                                    }\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:17014\",\n                                \"relatedGene\": {\n                                    \"id\": \"NCBIGene:2706\",\n                                    \"label\": \"GJB2\"\n                                },\n                                \"state\": \"\",\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NP_003995.2:p.Leu79Cysfs\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"protein\",\n                                \"referenceCoordinate\": {\n                                    \"referenceSequence\": {\n                                        \"label\": \"NP_003995.2\"\n                                    }\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:17014\",\n                                \"type\": \"ContextualAllele\"\n                            },\n                            {\n                                \"alleleName\": [\n                                    {\n                                        \"name\": \"NM_004004.5:c.235del\",\n                                        \"nameType\": \"hgvs\"\n                                    }\n                                ],\n                                \"contextualAlleleType\": \"transcript\",\n                                \"preferred\": true,\n                                \"referenceCoordinate\": {\n                                    \"end\": {\n                                        \"index\": 448\n                                    },\n                                    \"refState\": \"C\",\n                                    \"referenceSequence\": {\n                                        \"label\": \"NM_004004.5\"\n                                    },\n                                    \"start\": {\n                                        \"index\": 447\n                                    }\n                                },\n                                \"relatedCanonicalAllele\": \"ClinVar:17014\",\n                                \"relatedGene\": {\n                                    \"id\": \"NCBIGene:2706\",\n                                    \"label\": \"GJB2\"\n                                },\n                                \"state\": \"\",\n                                \"type\": \"ContextualAllele\"\n                            }\n                        ],\n                        \"relatedIdentifier\": [\n                            {\n                                \"id\": \"http://reg.genome.network/allele/CA127025\",\n                                \"label\": \"NM_004004.5(GJB2):c.235delC (p.Leu79Cysfs)\"\n                            },\n                            {\n                                \"id\": \"dbSNP:80338943\"\n                            }\n                        ],\n                        \"type\": \"CanonicalAllele\"\n                    }\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000325\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99028\",\n                        \"label\": \"PM2\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"Although the MAF (using the ExAC FAF) is .38% in  East Asians, BS1 is not contributing to the overall pathogenicity because this variant is on the HL ClinGen CDWG exclusion list.\",\n                    \"id\": \"/evaluations/3d6edcc8-d327-4a4d-ae41-3351707ac4dc/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:17014\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000216\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000328\",\n                            \"label\": \"Benign Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99039\",\n                        \"label\": \"BS1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"Although the MAF (using the ExAC FAF) is .38% in  East Asians, BS1 is not contributing to the overall pathogenicity because this variant is on the HL ClinGen CDWG exclusion list.\",\n                    \"id\": \"/evaluations/27fc6087-dfc3-4a06-94cb-ce5f72cfa29e/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:17014\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000328\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000329\",\n                            \"label\": \"Pathogenic Supporting\"\n                        },\n                        \"id\": \"SEPIO-CG:99035\",\n                        \"label\": \"PP3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"No splicing change predicted by MaxEntScan.\",\n                    \"id\": \"/evaluations/d5a5c7f5-2bd5-469b-ab14-fccb4dab0f6b/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000224\",\n                        \"label\": \"Not Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:17014\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000329\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000220\",\n                            \"label\": \"Pathogenic Very Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99022\",\n                        \"label\": \"PVS1\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"There are no alternate transcripts, the variant should results in NMD and lack of protein.\",\n                    \"id\": \"/evaluations/6c08885d-ce9b-4dc9-9cd9-13a1d6d773fe/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:17014\"\n                }\n            ],\n            \"evidenceStrength\": \"SEPIO:0000220\",\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000216\",\n                            \"label\": \"Pathogenic Moderate\"\n                        },\n                        \"id\": \"SEPIO-CG:99029\",\n                        \"label\": \"PM3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"This variant was identified in  >10 individuals with a pathogenic variant in trans. See the individuals publication notes below for case counts.\",\n                    \"evidenceLine\": [\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"This is a mutation analysis for Japanese non-syndromic hearing loss. The c.235delC variant was identified in 7 affected families. Two families were homozygous, three families were compound het for Y136X, and two families were compound het for R143W.\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/10633133\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"type\": \"EvidenceLine\"\n                        },\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"147 Korean patients with NSHL were screened for variants in GJB2. The c.235delC variant was identifed in 5 homozygous individuals and 5 compound hets. Because the het individuals did not have a second variant listed, I would only count the homozygous individuals here.\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/10983956\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"type\": \"EvidenceLine\"\n                        }\n                    ],\n                    \"id\": \"/evaluations/e02f03be-2aa4-4ffd-b061-38c8a4a02b47/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:17014\"\n                }\n            ],\n            \"evidenceStrength\": {\n                \"id\": \"SEPIO:0000220\",\n                \"label\": \"Pathogenic Very Strong\"\n            },\n            \"type\": \"EvidenceLine\"\n        },\n        {\n            \"evidenceItem\": [\n                {\n                    \"criterion\": {\n                        \"defaultStrength\": {\n                            \"id\": \"SEPIO:0000330\",\n                            \"label\": \"Pathogenic Strong\"\n                        },\n                        \"id\": \"SEPIO-CG:99025\",\n                        \"label\": \"PS3\",\n                        \"type\": \"VariantPathogenicityInterpretationCriterion\"\n                    },\n                    \"description\": \"A dye transfer assay demonstrated that there was no dye transfer in cells transfected with the c.235delC variant.\",\n                    \"evidenceLine\": [\n                        {\n                            \"evidenceItem\": [\n                                {\n                                    \"description\": \"HeLa cells were transfected with WT, mock transfected cells, or c.235delC constructs. Lucifer yellow was incubated with the cells for the dye transfer assay. Cells with the WT GJB2 demonstrated dye transfer, the negative control and the c.235delC cells had no dye transfer.\",\n                                    \"source\": [\n                                        \"https://www.ncbi.nlm.nih.gov/pubmed/12352684\"\n                                    ],\n                                    \"type\": \"Statement\"\n                                }\n                            ],\n                            \"type\": \"EvidenceLine\"\n                        }\n                    ],\n                    \"id\": \"/evaluations/73bbb907-7d42-468c-adff-a73b3cf468a9/\",\n                    \"statementOutcome\": {\n                        \"id\": \"SEPIO:0000223\",\n                        \"label\": \"Met\"\n                    },\n                    \"type\": \"CriterionAssessment\",\n                    \"variant\": \"ClinVar:17014\"\n                }\n            ],\n            \"evidenceStrength\": {\n                \"id\": \"SEPIO:0000216\",\n                \"label\": \"Pathogenic Moderate\"\n            },\n            \"type\": \"EvidenceLine\"\n        }\n    ],\n    \"id\": \"https://vci.clinicalgenome.org/interpretations/eda5030c-9ccf-4b14-bada-077b25b2562c/\",\n    \"statementOutcome\": {\n        \"id\": \"LOINC:LA6668-3\",\n        \"label\": \"Pathogenic\"\n    },\n    \"type\": \"VariantPathogenicityInterpretation\",\n    \"variant\": \"ClinVar:17014\"\n}]"
				},
				"url": {
					"raw": "http://35.196.45.74/invalidPath",
					"protocol": "http",
					"host": [
						"35",
						"196",
						"45",
						"74"
					],
					"path": [
						"invalidPath"
					]
				}
			},
			"response": []
		}
	]
}